OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
5
Results
Show all
Save search
Copy query
Show results for
Unknown
(5)
Release Date
2018
(1)
2016
(1)
2015
(1)
2014
(1)
2011
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Not available
S-EPMC5070550
|
biostudies-literature
Cite
Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Not available
S-EPMC6145831
|
biostudies-literature
Cite
Drosophila muller f elements maintain a distinct set of genomic properties over 40 million years of evolution.
Not available
S-EPMC4426361
|
biostudies-literature
Cite
Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization.
Not available
S-EPMC4124521
|
biostudies-literature
Cite
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure.
Not available
S-EPMC3445021
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets